180 Wealth Advisors, LLC Edwards Lifesciences Corp Transaction History

180 Wealth Advisors, LLC

$629 Million
Q3 2024

A detailed history of 180 Wealth Advisors, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, 180 Wealth Advisors, LLC holds 20,190 shares of EW stock, worth $1.5 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

20,190

Previous 10,215 97.65%

Holding current value

$1.5 Million

Previous $943,000 41.25%

% of portfolio

0.21%

Previous 0.16%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	BUY	$59.7 - $93.78 $595,507 - $935,455	9,975 Added 97.65%	20,190 $1.33 Million
Q2 2024 Jul 16, 2024	BUY	$84.3 - $94.31 $7,671 - $8,582	91 Added 0.9%	10,215 $943,000
Q1 2024 Apr 15, 2024	BUY	$72.54 - $95.56 $13,274 - $17,487	183 Added 1.84%	10,124 $967,000
Q4 2023 Jan 24, 2024	SELL	$61.71 - $77.76 $104,413 - $131,569	-1,692 Reduced 14.54%	9,941 $758,000
Q3 2023 Oct 31, 2023	BUY	$69.28 - $93.38 $94,012 - $126,716	1,357 Added 13.21%	11,633 $805,000
Q2 2023 Jul 11, 2023	SELL	$81.41 - $94.33 $103,309 - $119,704	-1,269 Reduced 10.99%	10,276 $969,000
Q1 2023 Apr 07, 2023	BUY	$74.26 - $84.51 $44,407 - $50,536	598 Added 5.46%	11,545 $955,000
Q4 2022 Feb 02, 2023	BUY	$68.3 - $87.44 $37,018 - $47,392	542 Added 5.21%	10,947 $816,000
Q3 2022 Oct 12, 2022	SELL	$82.37 - $107.29 $6,671 - $8,690	-81 Reduced 0.77%	10,405 $860,000
Q2 2022 Jul 11, 2022	BUY	$86.5 - $128.27 $7,525 - $11,159	87 Added 0.84%	10,486 $1.02 Million
Q1 2022 Apr 22, 2022	BUY	$101.96 - $128.34 $7,239 - $9,112	71 Added 0.69%	10,399 $1.3 Million
Q4 2021 Jan 26, 2022	BUY	$106.37 - $130.68 $53,185 - $65,340	500 Added 5.09%	10,328 $1.16 Million
Q3 2021 Oct 28, 2021	BUY	$102.91 - $122.75 $34,371 - $40,998	334 Added 3.52%	9,828 $1.1 Million
Q2 2021 Aug 13, 2021	SELL	$83.84 - $104.76 $4,192 - $5,238	-50 Reduced 0.52%	9,494 $1.06 Million
Q1 2021 May 25, 2021	BUY	$78.68 - $90.67 $394,894 - $455,072	5,019 Added 110.92%	9,544 $899,000
Q4 2020 Jan 27, 2021	BUY	$71.69 - $91.23 $103,807 - $132,101	1,448 Added 47.06%	4,525 $398,000
Q3 2020 Oct 23, 2020	SELL	$67.19 - $87.44 $154,066 - $200,499	-2,293 Reduced 42.7%	3,077 $260,000
Q2 2020 Jul 21, 2020	BUY	$57.54 - $76.95 $210,308 - $281,252	3,655 Added 213.12%	5,370 $398,000
Q1 2020 Apr 09, 2020	BUY	$52.41 - $81.0 $628 - $972	12 Added 0.7%	1,715 $317,000
Q4 2019 Jan 17, 2020	SELL	$71.7 - $82.09 $60,729 - $69,530	-847 Reduced 33.22%	1,703 $403,000
Q3 2019 Oct 22, 2019	SELL	$61.55 - $75.43 $21,480 - $26,325	-349 Reduced 12.04%	2,550 $579,000
Q2 2019 Aug 05, 2019	SELL	$55.74 - $64.41 $2,787 - $3,220	-50 Reduced 1.7%	2,899 $623,000
Q1 2019 May 14, 2019	SELL	$47.89 - $64.05 $14,223 - $19,022	-297 Reduced 9.15%	2,949 $526,000
Q3 2018 Nov 14, 2018	BUY	$45.7 - $58.03 $15,263 - $19,382	334 Added 11.47%	3,246 $565,000
Q2 2018 Aug 08, 2018	SELL	$42.45 - $51.3 $2,504 - $3,026	-59 Reduced 1.99%	2,912 $424,000
Q1 2018 Jun 01, 2018	BUY	$37.19 - $47.45 $110,491 - $140,973	2,971 New	2,971 $413,000

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

456M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $45.8B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of 180 Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 180 Wealth Advisors, LLC with notifications on news.

Account

180 Wealth Advisors, LLC Edwards Lifesciences Corp Transaction History